RecruitingNot ApplicableNCT07119957

ProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOsome

ProspEXPO : PROSPective Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOsome


Sponsor

University Hospital, Angers

Enrollment

300 participants

Start Date

Dec 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to build up a bio-collection of biological samples from patients with cirrhosis. Further work using this bio-collection will permit to describe the influence of different exposome factors (nutrition, physical activity, socio-demographic conditions, tobacco, alcohol, pollutants) on the occurrence of the main type of liver cancer (called HCC). Indeed, in the vast majority of cases, HCC develops within cirrhosis, and the factors that precipitate the progression of cirrhotic patients to HCC remain largely unknown.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood, urine and stool biocollection for people with carcinoma liver and cirrhoses, liver. The study is currently recruiting participants at 4 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood, urine and stool biocollection

Collection of blood, urine and stool sampling in order to build up a biocollection


Locations(4)

Angers University Hospital

Angers, France

Centre Eugène Marquis (Oncology center)

Rennes, France

Rennes University Hospital, Hepatogastroenteroly Department

Rennes, France

Tours University Hospital, HepatoGastroenterology Department

Tours, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07119957


Related Trials